ExpreS2ion Biotech Holding AB herby announces that the listing process at Nasdaq Stockholm First North has been delayed. The company will return shortly with more information.

Financial Advisors and Certified Advisor

Sedermera Fondkommission is appointed as Certified Adviser for the Company.

For further information about ExpreS2ion, please contact:

Steen Klysner, CEO
Telephone: +45 2062 9908
E-mail: sk@expres2ionbio.com

This press release contains information that ExpreS2ion is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.30 CET, July the 27th 2016.

Read the whole press release (pdf)